List of SBIR/STTR awards granted to Monogram Biosciences
A SBIR Phase II contract was awarded to Monogram Biosciences for $992,666.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $599,104.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Monogram Biosciences for $1,970,960.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $836,345.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Monogram Biosciences for $2,420,193.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Monogram Biosciences for $1,000,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $598,792.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $501,485.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $599,563.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Monogram Biosciences for $1,500,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $607,251.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $598,919.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $300,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Monogram Biosciences for $294,657.0 USD from the U.S. Department of Health & Human Services.
